a, vomiting, and/or diarrhea following paclitaxel use. If you experience nausea or stomach upset, tell your doctor. Diarrhea will usually disappear without treatment; however, if you experience severe abdominal or stomach area pain and/or severe diarrhea, tell your doctor right away.
Talk with your doctor or other healthcare professional to discuss ways to prevent or reduce some of these side effects. Because this leaflet does not include all possible side effects that can occur with paclitaxel, it is important to talk to your doctor about other possible side effects.
CAN I TAKE PACLITAXEL IF I AM PREGNANT OR NURSING A BABY?
Paclitaxel could harm the fetus when given to a pregnant woman. Women should avoid becoming pregnant while they are undergoing treatment with paclitaxel. Tell your doctor if you become pregnant or plan to become pregnant while taking paclitaxel.
Because studies have shown paclitaxel to be present in the breast milk of animals receiving the drug, it may be present in human breast milk as well. Therefore, nursing a baby while taking paclitaxel is NOT recommended.
This medicine was prescribed for your particular condition. This summary does not include everything there is to know about paclitaxel. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information Leaflet. If you have questions or concerns, or want more information about paclitaxel, your doctor and pharmacist have the complete prescribing information upon which this guide is based. You may want to read it and discuss it with your doctor. Remember, no written summary can replace careful discussion with your doctor.
This Patient Information Leaflet has been approved by the U.S. Food and Drug Administration.
Hospira, Inc.
Lake Forest, IL 60045
Product of Australia
Revision August 2007
483145
483144

483148

483150

PACLITAXEL
paclitaxel injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61703-342
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PACLITAXEL (PACLITAXEL) PACLITAXEL 6 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
POLYOXYL 35 CASTOR OIL
ALCOHOL
CITRIC ACID
Product Characteristics
Color Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:61703-342-09 1 VIAL, MULTI-DOSE (1 VIAL) in 1 CARTON contains a VIAL, MULTI-DOSE
1 5 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (61703-342-09)
2 NDC:61703-342-22 1 VIAL, MULTI-DOSE (1 VIAL) in 1 CARTON contains a VIAL, MULTI-DOSE
2 16.7 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (61703-342-22)
3 NDC:61703-342-50 1 VIAL, MULTI-DOSE (1 VIAL) in 1 CARTON contains a VIAL, MULTI-DOSE
3 50 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (61703-342-50)
Marketing Information
Marketing Cate